AC Immune SA
ACIU
$2.19
$0.041.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.69M | -21.17M | -17.99M | 6.36M | -25.17M |
| Total Depreciation and Amortization | 755.20K | 680.80K | 602.40K | 611.60K | 606.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.01M | 2.11M | -1.32M | -1.35M | 10.16M |
| Change in Net Operating Assets | 3.01M | -2.55M | 25.46M | -21.98M | 95.16M |
| Cash from Operations | -18.91M | -20.93M | 6.76M | -16.35M | 80.76M |
| Capital Expenditure | -452.20K | -402.70K | -102.50K | -195.40K | -75.20K |
| Sale of Property, Plant, and Equipment | 18.20K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.39M | 3.77M | -4.25M | -2.22M | -83.77M |
| Cash from Investing | 28.95M | 3.37M | -4.36M | -2.41M | -83.84M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -255.00K | -253.00K | -171.00K | -172.00K | -173.00K |
| Issuance of Common Stock | 3.00K | -- | -- | -- | 135.00K |
| Repurchase of Common Stock | -- | -- | -25.00K | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.00K | -5.00K | -1.00K | 0.00 | -24.00K |
| Cash from Financing | -299.40K | -287.00K | -224.30K | -200.00K | -68.60K |
| Foreign Exchange rate Adjustments | -2.76M | -299.20K | 2.22M | -3.17M | -2.87M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.99M | -18.15M | 4.39M | -22.14M | -6.02M |